Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Dice Molecules Announces $60 Million Series C-1 Financing
Company Info
Company news
Fri, 08 Jan 2021 08:00:00 GMT
DiCE Molecules Announces $80 Million Series C Financing - Business Wire
Tue, 20 Jun 2023 07:00:00 GMT
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology | Eli Lilly and Company - Investors | Eli Lilly and Company
Thu, 26 Aug 2021 07:00:00 GMT
Preclinical DiCE Molecules will roll its dice to Wall Street amid biotech IPO frenzy - Fierce Biotech
Tue, 11 Oct 2022 07:00:00 GMT
DICE Therapeutics Announces Positive Topline Data from - GlobeNewswire
Tue, 20 Jun 2023 07:00:00 GMT
Lilly makes fresh bet on IL-17 with $2.4B acquisition of Dice Therapeutics - Fierce Biotech
Mon, 03 May 2010 07:00:00 GMT
Densest dice packing and computing with molecules - Phys.org
Tue, 14 Sep 2021 07:00:00 GMT
DICE Therapeutics Announces Pricing of Upsized Initial Public Offering - GlobeNewswire
Wed, 09 Aug 2023 07:00:00 GMT
Lilly Completes Acquisition of DICE Therapeutics - PR Newswire
Thu, 11 May 2023 07:00:00 GMT
DICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights - GlobeNewswire
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.